
About Diagnos Laboratorium Utama
Diagnos Laboratorium Utama is a publicly listed company based in Jakarta (Indonesia) founded in 2017. Diagnostic test kits are manufactured for healthcare applications in Indonesia. The company has 96 employees. Its website diagnos.co.id draws about 26 thousand monthly visits. Diagnos Laboratorium Utama offers products and services including Genetic Testing and Medical Check-Up. Its focus areas include Traditional Diagnostics. Its legal entity is PT Diagnos Laboratorium Utama, Tbk.
Company details
Diagnos Laboratorium Utama was established in 2017 in Jakarta, Indonesia, as a manufacturer within the healthcare sector. Diagnostic test kits are produced by the company to support medical diagnostics. Operations are centered on kit development and production, with a focus on reliability for clinical use. The firm is led by Managing Director Dennis Jacobus, and activities are conducted primarily in Indonesia to meet regional demands.
- Headquarters Jakarta, Indonesia
- Employees 96
- Stage Public
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website diagnos.co.id
- Social LinkedIn Facebook Instagram
- Legal Name Pt Diagnos Laboratorium Utama Tbk
- Annual Revenue$9.97 M (USD)2.18as on Dec 31, 2025
- Net Profit$175.88 K (USD)292.95as on Dec 31, 2025
- EBITDA$981.12 K (USD)-4.08as on Dec 31, 2025
- Latest Funding Round$3.48M (USD), Debt – Conventional
Mar 2022
- Investors
- Employee Count96
Products & Services of Diagnos Laboratorium Utama
Diagnos Laboratorium Utama offers a comprehensive portfolio of products and services, including Genetic Testing and Medical Check-Up.
Genetic examinations are conducted by Diagnos to assess health risks and hereditary conditions, with services like DNAHope being utilized for accurate results.
Routine medical check-ups are provided by Diagnos, including homecare options and SARS-COV-2 testing, which are made available through various convenient channels.
Apps and channels of Diagnos Laboratorium Utama
Diagnos Laboratorium Utama publishes 2 mobile apps with over 10K+ downloads.
Funding Insights of Diagnos Laboratorium Utama
- Total Rounds 1
- Last Round Debt – Conventional β $3.48M
- First Round $3.48M
(Mar 2022)
- Investors Count 1
All 1 funding rounds of Diagnos Laboratorium Utama with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2022 | $3.48M | Debt – Conventional | β | β |
1 investors in total: 1 institutional.
Investors in Diagnos Laboratorium Utama
Diagnos Laboratorium Utama has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Bank Central Asia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Commercial banking services are offered to individuals and corporates. | 1957 | bca.co.id | Jakarta, Indonesia |
Investor details for Diagnos Laboratorium Utama
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Diagnos Laboratorium Utama
1 people are tracked at Diagnos Laboratorium Utama (1 in leadership); the tracked headcount is 96.
| Name | Role | Group |
|---|---|---|
Dennis Jacobus | Managing Director | Leadership |
Complete people profiles for Diagnos Laboratorium Utama
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Diagnos Laboratorium Utama
Diagnos Laboratorium Utama is a publicly listed company on the IDX with ticker symbol DGNS in Indonesia, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date15 Jan 2021
- Listed onIDX: DGNS
- Listed entityPT Diagnos Laboratorium Utama Tbk
- Exchange sectorHealth services
- ISINID1000158702
- Share price292.00 IDR (+1.39% on the day) · 2026-10-14
- Market capitalisation396,000,000,000.00 IDR
- Price to earnings166.0
- EPS (diluted, trailing year)1.76 IDR
- Volume (last session)1,992,500
Financials of Diagnos Laboratorium Utama
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 166.62B IDR | 2.94B IDR | 16.40B IDR |
| 2024 | 163.07B IDR | 747.4M IDR | 17.10B IDR |
| 2023 | 145.70B IDR | -13.66B IDR | 598.3M IDR |
| 2022 | 192.89B IDR | 12.66B IDR | 30.89B IDR |
| 2021 | 302.18B IDR | 64.30B IDR | 88.84B IDR |
Detailed financial statements for Diagnos Laboratorium Utama
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Diagnos Laboratorium Utama
3 dated milestones of Diagnos Laboratorium Utama across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Diagnos Laboratorium Utama is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $3.5M.
Web traffic of Diagnos Laboratorium Utama
The website of Diagnos Laboratorium Utama (diagnos.co.id) receives about 25.9K visits a month.
- Monthly visits25.9K
▼ 12.8% vs previous month
Websites whose visitors overlap most with Diagnos Laboratorium Utama. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
tanyadna.id | tanyadna.id | 100% | #2,842,910 | β | |
easydna.id | easydna.id | 96% | #2,955,258 | β |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Diagnos Laboratorium Utama
Diagnos Laboratorium Utama was founded in 2017 and raised its 1st funding round 5 years after it was founded.
Diagnos Laboratorium Utama is headquartered in Jakarta, Indonesia. It is registered at Jakarta, Jakarta, Indonesia.
Diagnos Laboratorium Utama has 96 employees.
Annual revenue of Diagnos Laboratorium Utama is $9.97M as on Dec 31, 2025.
Diagnos Laboratorium Utama was established in 2017 in Jakarta, Indonesia, as a manufacturer within the healthcare sector. Diagnostic test kits are produced by the company to support medical diagnostics. Operations are centered on kit development and production, with a focus on reliability for clinical use. The firm is led by Managing Director Dennis Jacobus, and activities are conducted primarily in Indonesia to meet regional demands.
Diagnos Laboratorium Utama offers Genetic Testing and Medical Check-Up.
Yes, Diagnos Laboratorium Utama is publicly traded on IDX under the ticker symbol DGNS.
Diagnos Laboratorium Utama has 1 investor. Key investors include Bank Central Asia.
Diagnos Laboratorium Utama operates through Pt Diagnos Laboratorium Utama, Tbk.
Yes. Diagnos Laboratorium Utama publishes DNAandMe and 1 more app, with over 10,000 downloads.